Context Hearing loss is the third most prevalent chronic condition in older
adults and has important effects on their physical and mental health. Despite
these effects, most older patients are not assessed or treated for hearing
loss.
Objective To review the evidence on screening and management of hearing loss of
older adults in the primary care setting.
Data Sources and Study Selection We performed a search from 1985 to 2001 using MEDLINE, HealthSTAR, EMBASE,
Ageline, and the National Guideline Clearinghouse for articles and practice
guidelines about screening and management of hearing loss in older adults,
as well as reviewed references in these articles and those suggested by experts
in hearing impairment.
Data Extraction We reviewed articles for the most clinically important information,
emphasizing randomized clinical trials, where available, and identified 1595
articles.
Data Synthesis Screening tests that reliably detect hearing loss are use of an audioscope,
a hand-held combination otoscope and audiometer, and a self-administered questionnaire,
the Hearing Handicap Inventory for the Elderly-Screening version. The value
of routine screening for improving patient outcomes has not been evaluated
in a randomized clinical trial. Screening is endorsed by most professional
organizations, including the US Preventive Services Task Force. While most
hearing loss in older adults is sensorineural and due to presbycusis, cerumen
impaction and chronic otitis media may be present in up to 30% of elderly
patients with hearing loss and can be treated by the primary care clinician.
In randomized trials, hearing aids have been demonstrated to improve outcomes
for patients with sensorineural hearing loss. Nonadherence to use of hearing
aids is high. Prompt recognition of potentially reversible causes of hearing
loss, such as sudden sensorineural hearing loss, is important to maximize
the possibility of functional recovery.
Conclusion While untested in a clinical trial, older adults can be screened for
hearing loss using simple methods, and effective treatments exist and are
available for many forms of hearing loss.
Epidemiology of hearing loss
Hearing loss is the third most prevalent chronic condition in older
Americans, after hypertension and arthritis1;
between 25% and 40% of the population aged 65 years or older is hearing impaired.1-4 The prevalence
rises with age, ranging from 40% to 66% in patients older than 75 years5-7 and more than 80% in
patients older than 85 years.3 Alternative
definitions of hearing loss would raise estimates of prevalence even higher.8 In addition, the impact of hearing loss on society
will increase not only because the population is aging, but also because the
prevalence of age-adjusted hearing loss has increased significantly since
the 1960s.9,10
The diminished ability to hear and to communicate is frustrating in
and of itself, but the strong association of hearing loss with depression
and functional decline adds further to the burden on individuals who are hearing
impaired.11-16 Hearing
loss in older patients strongly correlates with depression. For example, in
a study of 253 patients aged 70 years or older, a strong statistical association
was reported between the threshold of a low-frequency pure tone greater than
35 dB and depression.17 In addition, a cross-sectional
study of 1191 community-dwelling older persons aged 70 to 75 years found that
hearing impairment was significantly associated with depression as assessed
by the Beck Depression Inventory (odds ratio, 1.76; 95% confidence interval
[CI], 1.15-2.71).14 These associations have
been found to be independent of age and socioeconomic status.12 Furthermore,
Mulrow et al16 have reported the impact of
hearing loss on social isolation, poor self-esteem, and functional disability.
Other authors also have reported a strong relationship between hearing loss
and dementia.18,19
Despite the prevalence and burden of hearing loss, hearing impairment
is underdiagnosed in older persons. Only 9% of internists offer hearing testing
to patients aged 65 years or older.20 Hearing
loss also is undertreated: only 25% of patients with aidable hearing loss
receive hearing aids.3,21 The
underdetection and undertreatment of hearing loss are discouraging, because
strong evidence supports that the treatment of hearing loss improves quality
of life.22-25
Given the prevalence and disease burden of undetected hearing impairment
in older persons and the availability of effective treatments, it is important
for primary care physicians to screen, recognize, treat, and appropriately
refer patients with hearing impairment. This article reviews the literature
relevant to the care of older adults with hearing loss in the primary care
setting and provides insight into the treatment of hearing loss by hearing
specialists.
We conducted literature searches from 1985 to 2001 in the databases
MEDLINE, HealthSTAR, EMBASE, and Ageline, using search terms hearing, hearing loss, hearing aids, hearing impairment, screening, and other relevant terms. Articles chosen for review were
those with the most clinically important information, emphasizing randomized
clinical trials, when available. We identified 1595 articles. Additional articles
from our personal files and those suggested by experts in hearing impairment
were added. A further search was conducted for clinical practice guidelines
for hearing impairment in the literature and using the National Guideline
Clearinghouse Web site search (http://www.guidelines.gov). Details
of the search terms, databases used, and citations retrieved are available
from the authors.
Physiology of hearing loss
The healthy ear is an exquisitely sensitive organ. It processes sound
frequencies ranging from 20 Hz to 20 kHz. It detects sounds as soft as 0.0002
dynes/cm2 (0 dB) and can tolerate stimuli up to a million times
more intense (200 dynes/cm2 or 120 dB) for limited periods of exposure.
The ear is particularly sensitive to signals between 500 and 4000 Hz, which
includes the frequencies most important for speech processing.
The ear is composed of the external ear, the middle ear, and the inner
ear (Figure 1). The external ear
consists of the pinna (auricle) and the external auditory canal, and it is
immediately accessible to physical examination. Its function is thought to
be largely protective, although its physical configuration may provide moderate
(5-15 dB) passive augmentation of sounds at the upper range of speech processing
frequencies.
The middle ear is bounded laterally by the tympanic membrane (eardrum)
and medially by the osseous labyrinth, which is the bone-encased structure
that houses the end organs of hearing (cochlea) and balance (semicircular
canals). The healthy middle ear is an air-filled cleft that contains the 3
ossicles (malleus, incus, and stapes) that transduce vibrations from the tympanic
membrane to the oval window of the fluid-filled cochlea. The substantially
larger area of the tympanic membrane, compared with that of the oval window,
and the relatively minor mechanical gain from the ossicular configuration
combine to amplify sound pressures by 20 to 30 dB (approximately the difference
between a whispered voice and normal conversational speech).
The inner ear includes the cochlea, the vestibular apparatus, and the
vestibulocochlear (acoustic) nerve (cranial nerve VIII). The fluid channels
within the cochlea are stimulated by the vibrating stapes footplate through
the membranous oval window at the base of the cochlea. These fluid-filled
channels (scala vestibuli, tympani, and media) are lined by hair cells, which
are organized tonotopically (by sound frequency) in a coiled, spiral shape.
The base of the cochlea responds to high-frequency sounds, and the apex responds
to low-frequency sounds. Inner hair cells are innervated by a rich array of
afferent nerve fibers (10-20 fibers per hair cell) that synapse with auditory
division of the vestibulocochlear nerve at the spiral ganglion. Further discussion
of cochlear and brain stem physiology is beyond the scope of this review article.
The 2 major forms of hearing loss are conductive and sensorineural disorders.
Conductive hearing losses usually involve abnormalities of the middle and
external ear, and generally have a mechanical cause (eg, perforated eardrum,
fluid in the middle ear, disarticulations of the ossicular chain, cerumen
accumulation). As a result, treatment is often surgical (eg, repair of the
perforated eardrum, drainage of fluid-filled middle ear, reconstruction of
the ossicular chain, removal of cerumen). However, more than 90% of hearing
loss is sensorineural (nerve deafness), which typically results from permanent
damage to the hair cells of the cochlea.
Sensorineural loss related to aging, or presbycusis, is the most common
cause of hearing loss in the United States. This type of hearing loss is typically
gradual, bilateral, and characterized by high-frequency hearing loss. Patients
with presbycusis typically have difficulty filtering background noise, which
makes listening especially challenging in common social settings. Because
no known treatment is available for damaged hair cells, presbycusis is typically
treated with amplification devices, such as hearing aids. Note that profound
deafness can be treated with cochlear implantation, which bypasses the hair
cells to stimulate the vestibulocochlear nerve directly.
Criteria for a Screening Program
The value of routine screening for undiagnosed hearing impairment has
not been studied in clinical trials. In the absence of direct clinical trial
data, screening programs can be advocated if evidence is available to support
each of the 3 commonly accepted criteria for a community screening program.26,27 These criteria are that (1) the burden
of disease must be significant enough to justify the effort of screening,
(2) an effective treatment must be available for the detected condition, and
(3) an accurate, practical, and convenient screening test must exist. Mulrow
and Lichenstein28 have argued that these conditions
are satisfied for screening hearing impairment. The US Preventive Service
Task Force, the Canadian Task Force on Preventive Health Care (formerly called
the Canadian Task Force on the Periodic Health Examination), and other groups
have concurred and recommend screening older adults for hearing impairment
(Table 1).27,29,30
Although screening tests exist and effective treatment is available,
it has not been established that routine screening leads to improved long-term
outcomes. The first clinical trial to study long-term outcomes after routine
screening for hearing impairment in older adults is now under way by the Screening
for Auditory Impairment-Which Hearing Aid Test trial, conducted by the Health
Service Research and Development Service of the Veterans Health Administration.31
In addition, routine screening may be helpful because it is difficult
to diagnose hearing loss in the primary care setting. The onset of presbycusis
is insidious and patients themselves are frequently unaware of their hearing
loss. Physicians may overlook presbycusis in a quiet examination room, since
the symptoms of early presbycusis are more apparent in settings with background
noise. In addition, the diagnosis of hearing loss must be confirmed with formal
audiometric testing, which is the diagnostic criterion standard.
Many simple tests for hearing loss have been used as a routine part
of the physical examination, but they are difficult to implement in systematic
screening programs because they cannot be standardized. For example, the Whispered
Voice Test is performed by examiners who whisper words from behind the patient
at varying distances.32,33 The
degree of hearing loss is reflected by the furthest distance from which patients
may still reliably reproduce what is whispered. Attempts to standardize the
test have been made (eg, by whispering only after full expiration), but there
is no reliable way to control the loudness of the whispers, and robust descriptions
of interobserver variability and test-retest reliability are lacking.31,34 Screening with a vibrating tuning
fork or the sounds of an examiner's fingers rubbing also has been proposed.32,35 Judgments about hearing loss generally
rely on measuring the threshold distance beyond which the sounds cannot be
heard. Alternatively, the hearing thresholds of the patient and the examiner
can be compared by placing the vibrating tuning fork on each person's mastoid
process (Schwabach test). Again, although reasonable test accuracy has been
reported in small series,32,35 the
intrinsically subjective nature of these tests (What is the degree of the
examiner's hearing loss? How hard should the tuning fork be struck?34) is a serious limitation.28
In contrast, 2 inexpensive and simpler approaches to screening—a
self-administered questionnaire and a simple physiologic test—have demonstrated
excellent accuracy in detecting hearing loss and have gained widespread interest.
Hearing Handicap Inventory for the Elderly-Screening. The self-administered instrument is the Hearing Handicap Inventory
for the Elderly-Screening version (HHIE-S),36,37 a
10-item, 5-minute questionnaire that measures the degree of social and emotional
handicap from hearing loss (Box 1).
Box Section Ref IDBox 1. Questions From Hearing Handicap Inventory for the Elderly-Screening
Version (HHIE-S)*
Does a hearing problem cause you to feel embarrassed
when meeting new people?
Does a hearing problem cause you to feel frustrated
when talking to members of your family?
Do you have difficulty hearing when someone speaks
in a whisper?
Do you feel handicapped by a hearing problem?
Does a hearing problem cause you difficulty when
visiting friends, relatives, or neighbors?
Does a hearing problem cause you to attend religious
services less often than you would like?
Does a hearing problem cause you to have arguments
with family members?
Does a hearing problem cause you difficulty when
listening to TV or radio?
Do you feel that any difficulty with your hearing
limits or hampers your personal or social life?
Does a hearing problem cause you difficulty when
in a restaurant with relatives or friends?
*The HHIE-S scores are yes, 4 points; sometimes, 2 points; or no, 0
points, to each question about a particular handicap. Scores range from 0
(no handicap) to 40 (maximum handicap). Adapted with permission.36,37
The patient responds yes (4 points), sometimes (2 points), or no (0
points) to each question about a particular handicap. Scores range from 0
(no handicap) to 40 (maximum handicap). A total score of 0 to 8 indicates
a 13% probability of hearing impairment, a score of 10 to 24 indicates a 50%
probability of a hearing impairment, and a score of 26 to 40 indicates an
84% probability of a hearing impairment.38
Several cross-sectional studies 7,36,38-41 have
investigated the performance of the HHIE-S. Each study has a slightly different
patient population and definition of hearing loss, but substantial evidence
shows that patients with abnormal HHIE-S scores have high rates of hearing
impairment. Cutoff scores of 10 and above provide reasonable sensitivity and
specificity, with values for both scores ranging from 0.63 to 0.80 (Table 2). It should be emphasized that
the HHIE-S screens for functional not physiologic hearing loss. Therefore,
when audiometric testing (a physiologic measure) is used as the criterion
standard, the sensitivity of the HHIE-S appears low. Higher cutoff scores
provide significantly improved specificity and likelihood ratios (data not
shown), but poorer sensitivity.
Audioscope. The physiologic test uses an audioscope,
a hand-held, combination otoscope and audiometer that delivers a 25- to 40-dB
pure tone at 500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz, the most commonly tested
frequencies needed to hear speech. The listed price for the Audioscope (Welch
Allyn Medical Products, Skaneateles Falls, NY) is $500 to $600, according
to the company's Web site (http://www.welchallyn.com/medical/).
The audioscope is held directly in the external auditory (ear) canal with
a probe tip sealing the canal. Tones are presented at each frequency, and
the listener is asked to indicate whether he or she can hear the tone.6 Minimal training is required. Patients unable to hear
a predetermined series of tones may then be referred for formal evaluation.
Audioscope testing is recommended by the Canadian Task Force on Preventive
Health Care.30 In addition to screening for
hearing loss, the audioscope also allows for direct inspection of the ear
canal to assess external ear abnormalities, such as cerumen, otitis, and foreign
bodies.
The audioscope also has been tested against the diagnostic criterion
standard of formal audiogram in several reports (Table 3).7,38,40 Each
study used the 40-dB threshold for both screening and audiometry, which is
the threshold that the Veterans Health Administration uses to adjudicate hearing
loss.42 Despite small differences in methods,
all 3 studies7,38,40 demonstrated
excellent sensitivity (≥0.94) and good specificity (0.69-0.80) for hearing
loss. Each study concluded that the most efficient screening frequencies would
be at 2 kHz,7,40 or a combination
of 1 and 2 kHz.38 These studies also tested
the performance of the HHIE-S, and the study by McBride et al40 concluded
from the performance using receiver-operating curves for both the HHIE-S and
the audioscope (using the formal audiometric testing as the criterion standard)
that the audioscope performed better. A review of 185 patients aged 60 years
or older who were screened consecutively by both the audioscope and the HHIE-S
in a primary care clinic reported that patients preferred the audioscope (60%)
over the HHIE-S (13%) as a screening tool.40
Because the HHIE-S and the audioscope screen different aspects of hearing
loss, it is possible that they preferentially identify different types of
hearing-impaired patients. The audioscope detects only physiologic loss, so
it may identify more patients with hearing loss,40 but
not necessarily those patients who are motivated to seek treatment. On the
other hand, because the HHIE-S identifies individuals with handicap from hearing
loss, it may be less sensitive to early disease, but more likely to identify
motivated individuals. Therefore, it is unclear whether the HHIE-S or the
audioscope is likely to be more successful in detecting hearing impairment.
Several authors have proposed that a combination of both physiologic and self-report
screenings may represent a viable third alternative,38,40 which
is the focus of the ongoing Screening for Auditory Impairment-Which Hearing
Aid Test trial.31
Treatment of hearing loss in the primary care clinic
Several otologic abnormalities can be identified and treated by the
primary care physician. Cerumen impaction may result in substantial hearing
loss and can be found in up to 30% of elderly patients with hearing loss.43 If physical inspection of the external auditory canal
reveals cerumen impaction, the cerumen may be removed by several techniques.
A small cerumen curette, if available, may be used to remove the cerumen if
the practitioner is comfortable and familiar with this technique. Alternatively,
gentle warm water irrigation may be used to loosen and remove the cerumen
if the patient has no history of tympanic membrane perforation or ear surgery.
Hydrogen peroxide–containing solutions (sold over-the-counter, such
as Debrox or Murine) can be prescribed to loosen firm cerumen impactions if
the patient has no history of tympanic membrane perforation or ear surgery.
Deep cerumen impactions may be resistant to these maneuvers and the patient
can be referred to an otolaryngologist for safe removal of the cerumen under
microscopic examination.
Chronic otitis media with effusion is a common problem in older adults.
This condition, also known as serous otitis since
the middle ear becomes filled with a serous fluid, may result in discomfort
and a conductive hearing loss. We were unable to identify any randomized,
placebo-controlled trials that documented the efficacy of antibiotic therapy
or other treatments in older adults with this condition. In children, systematic
reviews of randomized placebo-controlled trials suggest that antibiotics44,45 and oral steroids46,47 both
shorten the course of disease, but that decongestants and antihistamines had
no significant effect on effusion clearance.44,48 Serous
otitis may persist for weeks or months, and such patients should be referred
to an otolaryngologist either for more aggressive treatment (eg, surgical
aspiration of fluid) or to rule out an underlying disorder with resultant
obstruction of the eustachian tube (eg, nasopharyngeal carcinoma).
Sudden Sensorineural Hearing Loss
Early intervention by the astute primary care physician may halt or
reverse 2 forms of sensorineural hearing loss: unilateral sudden sensorineural
hearing loss (or sudden deafness) and hearing loss caused by ototoxicity.
Sudden Hearing Loss. The etiology of sudden
sensorineural hearing loss is not yet clear. A variety of mechanisms ranging
from viral infections to microcirculatory injuries to immune-mediated disorders
have been proposed,49,50 although
expert opinion is that viral infection may be the most important contributor.50-52 However, 2 recent
randomized trials failed to show benefit from antiviral agents.53,54 To
date, the only treatment to show efficacy in placebo-controlled trials has
been glucocorticoid administration. In an earlier randomized trial, nearly
twice as many patients (61% vs 32%) receiving glucocorticoids experienced
at least partial recovery of hearing as those receiving placebo.55 To
document the hearing loss, and to rule out masquerading retrocochlear processes
such as acoustic neuromas,56,57 these
patients should be referred urgently for specialty care.
Ototoxicity. The ototoxic effects of antibiotics
and antineoplastic agents are well documented. The aminoglycosides and platinum
compounds are particularly ototoxic, but a variety of other agents have been
implicated as well in case reports (Box 2).58-63 When
known ototoxic agents need to be administered, ultra high-frequency audiometry
is available for early detection of ototoxicity in adult populations,64 but currently no guidelines are available on the
use of ultra high-frequency audiometry. Because high-frequency hearing loss
usually precedes loss in the normal range, early detection of such loss may
lead to modifications in treatment that prevent clinically important hearing
loss. A frequently overlooked ototoxic agent is aspirin. Little is known about
what level of dosage causes ototoxicity, but it is generally believed that
80 mg of aspirin on a daily basis is safe. Fortunately, in most cases, the
resulting tinnitus and hearing loss are temporary and reversible with cessation
of aspirin.65,66
Antibiotics: aminoglycosides, erythromycin, and vancomycin
Antineoplastics: cisplatin, carboplatin, and vincristine sulfate
Loop diuretics: furosemide, ethacrynic acid
Anti-inflammatory: aspirin and quinine
When disease management lies beyond the scope of the primary care setting,
it is important to refer patients to hearing specialists for additional evaluation.
Audiometric testing by audiologists is not only the criterion standard for
diagnosing hearing loss, but critical for determining whether hearing loss
is sensorineural or conductive in origin, which strongly influences choice
of therapy. It is important to recognize that certain hearing disorders, such
as traumatic injury with vestibular symptoms and/or deafness, and erosive
lesions, such as cholesteatoma, require urgent consultation.
Treatment of hearing loss by hearing specialists
Referrals for hearing loss are best directed to audiologists, otolaryngologists,
or both. Audiologists have expertise in hearing testing, use of assistive
listening devices (eg, telephone amplifiers, infrared systems, pocket talkers,
and visual/tactile alerts for the doorbell, telephone, and smoke alarm), and
the selection and fitting of hearing aids. Otolaryngologists have specialty
training in a range of disorders in the head and neck, which include the medical
and surgical treatment of otologic problems.
The first step in the clinical workup of hearing loss is formal audiometric
testing by an audiologist. The audiometric tests are performed in a sound-protected
environment. These tests include a standard test battery consisting of pure-tone
audiometry that assesses the patient's threshold of hearing for tones from
low frequency (250 Hz) to high frequency (8 kHz); word recognition tests that
measure the percentage of monosyllabic words that a patient can repeat (discrimination
scores); the speech reception threshold that measures the lowest intensity
level at which a patient can repeat 50% of spondaic words (ie, 2-syllable
words with equal emphasis on each syllable, such as baseball, cowboy, and
pancake); and bone-conduction testing, acoustic reflexes, and tympanometry,
which primarily target the presence or absence of specific disorders, such
as otosclerosis, acoustic neuromas, or otitis media.
The majority of hearing loss is sensorineural. In mild-to-severe loss,
the most effective treatment is hearing amplification with hearing aids. In
a seminal randomized clinical trial of 194 elderly veterans, patients randomly
assigned to receive a hearing aid experienced significant improvements in
social and emotional function, communication function, and depression after
4 months, compared with patients in the control group.22 The
authors subsequently found that the improvements were sustained 1 year after
being fit with a hearing aid.23 These findings
were confirmed by a cross-over trial involving 180 older patients, comparing
a hearing aid, an assistive listening device, and in combination.24 The most significant improvements in emotional and
social function were noted with the hearing aid. More recently, in a 4-arm,
randomized trial of 60 older veterans comparing 2 types of hearing aids and
2 types of control arms, substantial improvements in quality-of-life measures,
communication function, patient preferences, and adherence were noted for
patients using hearing aids, with particular preference for a programmable
hearing aid with a directional microphone.25
However, treatment effectiveness is not guaranteed even if patients
receive hearing aids. Nonadherence to use of hearing aids is high. Several
authors have conservatively estimated that up to 30% of patients who receive
hearing aids do not use their aids.3,67-69 As
patients age, handling the hearing aid can become increasingly difficult.70 Older patients experience more problems with inserting
the earmold into the ear, switching on and off the hearing aid, changing the
battery, cleaning the earmold, and changing the volume.71 These
difficulties are among the most common explanations for failure to wear a
hearing aid. Among a group of 138 hearing aid users who were older than 90
years, 33% to 79% experienced difficulty with any or all of these tasks.5 However, age (or any other predetermined variable)
has not yet been identified as an accurate predictor of hearing aid use. In
a group of 87 elderly male veterans, variables such as subjective functional
handicap, age, education, and number of medications had no consistent correlation
with hearing aid use.23
A number of hearing aid technologies have been a focus of study, including
digital sound processing. Despite the promise of this technology, to date,
little evidence is available to show that digital hearing aids result in improved
hearing, since no trials involving digital technology have used adequate concurrent
control groups.72 Valente et al73 have
suggested that features, such as directional microphones confound existing
comparisons between digital and analog hearing aids. Another recent study
found that expectations strongly influence outcomes in patients who receive
digital aids.74 The investigators provided
digital aids to the entire cohort, but they led half of the patients to believe
that they received analog aids. Significantly lower satisfaction rates were
observed in these patients. Since digital hearing aids cost substantially
more than analog hearing aids, they cannot yet be considered cost-effective.
However, advances in digital technology may lower cost and improve effectiveness
and thereby improve the cost-effectiveness ratio.
The size and shape of hearing aids may influence satisfaction. In one
randomized study, 244 elderly patients were fitted with either behind-the-ear,
in-the-ear, or in-the-canal hearing aids.75 The
in-the-ear aid was rated as the easiest to manipulate, but surprisingly, cosmetic
judgments were unaffected by the size of the hearing aid.76 Another
study of 40 patients compared patient satisfaction with behind-the-ear vs
in-the-canal hearing aids.77 Patients with
in-the-canal hearing aids used their aids more frequently than patients with
behind-the-ear aids (45.4 h/wk vs 19.5 h/wk, P<.005).
In both studies, patients with behind-the-ear aids reported significantly
more "undesirable experiences" (operational difficulties, ear discomfort,
and negative sound experiences).76,77
Audiologists also commonly use assistive listening devices in auditory
rehabilitation.78 We are unaware of randomized
controlled trials demonstrating that assistive listening devices have benefit
over placebo. However, these devices have face validity and are commonly accepted
and prescribed by audiologists. In patients with moderate hearing loss, devices
such as infrared systems and telephone amplifiers may supplement the use of
hearing aids. For patients with profound hearing loss in whom conventional
amplification is unsuccessful, frequency-modulated systems, consisting of
a microphone placed near the source of sound, a transmitter, and a receiver
worn by the patient, are commonly used. In addition, visual and/or tactile
alerts for the doorbell, telephone, and smoke detector have been used in place
of hearing aids.79,80
Otolaryngology Treatments
Surgical treatment of common causes of hearing loss are briefly discussed.
Less common causes of hearing loss, such as acoustic neuromas, are beyond
the scope of this review. Because few controlled trials of surgical treatment
of hearing loss in adults have been conducted, our intent is not to provide
a formal evidence-based review, but rather to provide the primary care physician
with insight into how patients are treated after referral.
For persistent chronic otitis media with effusions, the use of myringotomy
(incision in the tympanic membrane) and pressure-equalization tubes are routinely
used to aspirate the contents and aerate the middle ear cleft, which immediately
restores hearing. It also is important for the otolaryngologist to examine
the patient's nasopharynx to rule out both benign (eg, allergic disease) and
malignant (eg, nasopharyngeal carcinoma) underlying conditions that might
obstruct the eustachian tube and predispose the patient to otitis media.
Small tympanic membrane perforations from recent traumatic events or
otitis media frequently heal spontaneously (Figure 2). However, large persisting perforations may cause substantial
conductive hearing loss and predispose patients to recurrent otitis. Surgical
repair of the perforation with fascial grafts (tympanoplasty) has an extremely
high success rate. Ossicular chain discontinuities also may result from trauma
or long-standing ear infections and are readily treated with ossicular chain
reconstructions using transposed ossicles or surgical implants.
A cholesteatoma is a cystic mass of the middle ear or mastoid cavity
that contains trapped squamous epithelium (Figure 2). It is not a neoplasm, but the slowly growing mass can
destroy surrounding structures, including the ossicles. Patients with chronic
ear infections are predisposed to cholesteatoma formation. Examination frequently
reveals a superior and posterior tympanic membrane perforation, with the presence
of white keratinaceous debris. No medical treatment for cholesteatoma is currently
available, although topical antibiotic drops may help to alleviate superinfections.
Surgery (mastoidectomy) is required to remove the cholesteatoma.
Bony sclerosis of the otic capsule is termed otosclerosis. When this common condition involves the stapes footplate, immobility
of the stapes prevents sound transduction to the oval window. This typically
results in a conductive hearing loss.81 Otoscopic
examination results of a patient with otosclerosis are most often normal.
Surgery on the footplate (stapedectomy or stapedotomy) provides excellent
aural rehabilitation. Hearing aids may be an alternative if surgery is not
appropriate. Elderly patients should be offered both options since several
studies have shown no increased surgical risk based on age alone, and they
appear to benefit from the surgery as much as younger patients.82-84
Profound sensorineural hearing loss (defined as >80 dB of loss in the
better ear), or true deafness, is increasingly amenable to treatment with
cochlear implantation. Rapid technological advances in implant technology
in the past 2 decades has led to successful rehabilitation of these patients
who previously had no reasonable alternative forms of treatment. Much of the
literature has focused on the effectiveness of treatment in the pediatric
population,85 but recent findings from systematic
reviews86 and prospective cohorts87,88 suggest
that cochlear implantation results in such substantial improvements in quality
of life, and patient preference states that implantation is cost-effective
in the adult patient as well.
Substantial evidence exists that hearing loss in older persons is underdiagnosed
and undertreated, despite the availability of effective treatment. The primary
care physician should vigilantly ask about hearing loss in older patients
and recognize common symptoms of hearing impairment, such as communication
impairment and social withdrawal. A variety of screening tests are available
for use in the primary care setting, most notably the portable audioscope
and the HHIE-S questionnaire. The Screening for Auditory Impairment-Which
Hearing Aid Test trial will assess whether mass screening leads to better
patient outcomes; results are expected in 2005. In the meantime, it seems
reasonable to provide hearing screening to older patients using either the
audioscope or HHIE-S. Many cases of hearing loss are treatable in the primary
care setting, and prompt recognition of sudden hearing loss may prevent further
deterioration or permanent deafness. In addition, recognition of hearing loss
facilitates referral to appropriate hearing professionals for treatment that
may lead to better quality of life.
1.Cruickshanks KJ, Wiley TL, Tweed TS.
et al. Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin:
the Epidemiology of Hearing Loss Study.
Am J Epidemiol.1998;148:879-886.Google Scholar 2.US Department of Commerce. Statistical Abstract of the United States. 117th ed. Washington, DC: US Census Bureau; 1997.
3.Gates GA, Cooper Jr JC, Kannel WB, Miller NJ. Hearing in the elderly: the Framingham cohort, 1983-1985; part I: basic
audiometric test results.
Ear Hear.1990;11:247-256.Google Scholar 4.Rueben D, Walsh K, Moore A.
et al. Hearing loss in community-dwelling older persons: national prevalence
data and identification using simple questions.
J Am Geriatr Soc.1998;46:1008-1011.Google Scholar 5.Parving A, Philip B. Use and benefit of hearing aids in the tenth decade and beyond.
Audiology.1991;30:61-69.Google Scholar 6.Rahko T, Kallio V, Kataja M, Fagerstrom K, Karma P. Prevalence of handicapping hearing loss in an aging population.
Ann Otol Rhinol Laryngol.1985;94(2 pt 1):140-144.Google Scholar 7.Ciurlia-Guy E, Cashman M, Lewsen B. Identifying hearing loss and hearing handicap among chronic care elderly
people.
Gerontologist.1993;33:644-649.Google Scholar 8.Moscicki EK, Elkins EF, Baum HM, McNamara PM. Hearing loss in the elderly: an epidemiologic study of the Framingham
Heart Study Cohort.
Ear Hear.1985;6:184-190.Google Scholar 9.Wallhagen MI, Strawbridge WJ, Cohen RD, Kaplan GA. An increasing prevalence of hearing impairment and associated risk
factors over three decades of the Alameda County Study.
Am J Public Health.1997;87:440-442.Google Scholar 10.Ries PW. Prevalence and characteristics of persons with hearing trouble: United
States, 1990-91.
Vital Health Stat 10.1994;188:1-75.Google Scholar 11.Kay DW, Roth M, Beamish P. Old age mental disorders in Newcastle upon Tyne; II: a study of possible
social and medical causes.
Br J Psychol.1964;110:668-682.Google Scholar 12.Herbst KG, Humphrey C. Hearing impairment and mental state in the elderly living at home.
BMJ.1980;281:903-905.Google Scholar 13.LaForge RG, Spector WD, Sternberg J. The relationship of vision and hearing impairment to one-year mortality
and functional decline.
J Aging Health.1992;4:126-148.Google Scholar 14.Carabellese C, Appollonio I, Rozzini R.
et al. Sensory impairment and quality of life in a community elderly population.
J Am Geriatr Soc.1993;41:401-407.Google Scholar 15.Appollonio I, Carabellese C, Frattola L, Trabucchi M. Effects of sensory aids on the quality of life and mortality of elderly
people: a multivariate analysis.
Age Ageing.1996;25:89-96.Google Scholar 16.Mulrow CD, Aguilar C, Endicott JE.
et al. Association between hearing impairment and the quality of life of elderly
individuals.
J Am Geriatr Soc.1990;38:45-50.Google Scholar 17.Gurland BJ, Kuriansky JB, Sharpe L, Simon R, Stiller P, Birkett P. The Comprehensive Assessment and Referral Evaluation (CARE)—rationale,
development, and reliability.
Int J Aging Hum Dev.1977;8:9-42.Google Scholar 18.Uhlmann RF, Larson EB, Rees TS, Koepsell TD, Duckert LG. Relationship of hearing impairment to dementia and cognitive dysfunction
in older adults.
JAMA.1989;261:1916-1919.Google Scholar 19.Gates GA, Cobb JL, Linn RT, Rees T, Wolf PA, D'Agostino RB. Central auditory dysfunction, cognitive dysfunction, and dementia in
older people.
Arch Otolaryngol Head Neck Surg.1996;122:161-167.Google Scholar 20.US Department of Health and Human Services, Centers for Disease Control,
National Center for Health Statistics. Health People 2000 Review, 1995-96. Washington, DC: National Center for Health Statistics; 1997.
21.Kochkin S. MarkeTrak IV. What is the viable market for hearing aids?
Hearing J.1997;50:31-39.Google Scholar 22.Mulrow CD, Aguilar C, Endicott JE.
et al. Quality-of-life changes and hearing impairment: a randomized trial.
Ann Intern Med.1990;113:188-194.Google Scholar 23.Mulrow CD, Tuley MR, Aguilar C. Sustained benefits of hearing aids.
J Speech Hear Res.1992;35:1402-1405.Google Scholar 24.Jerger J, Chmiel R, Florin E, Pirozzolo F, Wilson N. Comparison of conventional amplification and an assistive listening
device in elderly persons.
Ear Hear.1996;17:490-504.Google Scholar 25.Yueh B, Souza P, McDowell J, Bryant M, Loovis CF, Deyo R. Randomized trial of amplication strategies.
Arch Otolaryngol Head Neck Surg.2001;127:1197-1204.Google Scholar 26.Cadman D, Chambers L, Feldman W, Sackett D. Assessing the effectiveness or community screening programs.
JAMA.1984;251:1580-1585.Google Scholar 27.Nielsen C, Lang RS. Principles of screening.
Med Clin North Am.1999;83:1323-1337.Google Scholar 28.Mulrow CD, Lichtenstein MJ. Screening for hearing impairment in the elderly: rationale and strategy.
J Gen Intern Med.1991;6:249-258.Google Scholar 29.US Preventive Service Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
30.Canadian Task Force on Preventive Health Care. Canadian Guide to Clinical Preventive Health Care. Ottawa, Ontario: Canada Communication Group; 1994.
31.Yueh B, Souza P, Collins M.
et al. Screening for Auditory Impairment: Which Hearing Aid Test? A Randomized Clinical Trial. Seattle, Wash; Dept of Veterans Affairs
Merit Review, funded by the Health Services Research and Development Service;
2001.
32.Uhlmann RF, Rees TS, Psaty BM, Duckert LG. Validity and reliability of auditory screening tests in demented and
non-demented older adults.
J Gen Intern Med.1989;4:90-96.Google Scholar 33.Macphee GJ, Crowther JA, McAlpine CH. A simple screening test for hearing impairment in elderly patients.
Age Ageing.1988;17:347-351.Google Scholar 34.Rintelmann WF. Hearing Assessment. 2nd ed. Austin, Tex: Pro-Ed Inc; 1990.
35.Matteson MA, Linton A, Byers V. Vision and hearing screening in cognitively impaired older adults.
Geriatr Nurs.1993;14:294-297.Google Scholar 36.Ventry IM, Weinstein BE. Identification of elderly people with hearing problems.
ASHA.1983;25:37-42.Google Scholar 37.Weinstein BE. Validity of a screening protocol for identifying elderly people with
hearing problems.
ASHA.1986;28:41-45.Google Scholar 38.Lichtenstein MJ, Bess FH, Logan SA. Validation of screening tools for identifying hearing-impaired elderly
in primary care.
JAMA.1988;259:2875-2878.Google Scholar 39.Lichtenstein MJ, Bess FH, Logan SA. Diagnostic performance of the Hearing Handicap Inventory for the Elderly
(Screening version) against differing definitions of hearing loss.
Ear Hear.1988;9:208-211.Google Scholar 40.McBride WS, Mulrow CD, Aguilar C, Tuley MR. Methods for screening for hearing loss in older adults.
Am J Med Sci.1994;307:40-42.Google Scholar 41.Mulrow CD, Tuley MR, Aguilar C. Discriminating and responsiveness abilities of two hearing handicap
scales.
Ear Hear.1990;11:176-180.Google Scholar 42.US Congress. Numeric designation of hearing impairment.
Federal Register.1987;52:44120.Google Scholar 43.Lewis-Culinan C, Janken J. Effect of cerumen removal on the hearing ability of geriatric patients.
J Adv Nursing.1990;15:594-600.Google Scholar 44.Stool SE, Berg SO, Berman S. Otitis Media With Effusion in Young Children: Clinical
Practice Guideline Number 12. Rockville, Md: Agency for Health Care Policy and Research, Public
Health Service, US Dept of Health and Human Services; 1994. AHCPR Publication
94-0622.
45.Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in
treating otitis media with effusion: a meta-analytic attempt to resolve the
brouhaha.
JAMA.1993;270:1344-1351.Google Scholar 46.Rosenfeld RM, Mandel EM, Bluestone CD. Systemic steroids for otitis media with effusion in children.
Arch Otolaryngol Head Neck Surg.1991;117:984-989.Google Scholar 47.Butler CC, van Der Voort JH. Steroids for otitis media with effusion: a systematic review.
Arch Pediatr Adolesc Med.2001;155:641-647.Google Scholar 49.Alexiou C, Arnold W, Fauser C.
et al. Sudden sensorineural hearing loss: does application of glucocorticoids
make sense?
Arch Otolaryngol Head Neck Surg.2001;127:253-258.Google Scholar 50.Eisenman D, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss.
Arch Otolaryngol Head Neck Surg.2000;126:1161-1164.Google Scholar 51.Tucci DL. Sudden sensorineural hearing loss: a viral etiology?
Arch Otolaryngol Head Neck Surg.2000;126:1164-1165.Google Scholar 52.Hashisaki GT. Which treatment for sudden sensorineural hearing loss?
Arch Otolaryngol Head Neck Surg.2000;126:1165-1166.Google Scholar 53.Tucci DL, Farmer Jr JC, Kitch RD, Witsell DL. Treatment of sudden sensorineural hearing loss with systemic steroids
and valacyclovir.
Otol Neurotol.2002;23:301-308.Google Scholar 54.Stokroos RJ, Albers FW, Tenvergert EM. Antiviral treatment of idiopathic sudden sensorineural hearing loss:
a prospective, randomized, double-blind clinical trial.
Acta Otolaryngol.1998;118:488-495.Google Scholar 55.Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing
loss: a double-blind clinical study.
Arch Otolaryngol.1980;106:772-776.Google Scholar 56.Friedman RA, Kesser BW, Slattery 3rd WH, Brackmann DE, Hitselberger WE. Hearing preservation in patients with vestibular schwannomas with sudden
sensorineural hearing loss.
Otolaryngol Head Neck Surg.2001;125:544-551.Google Scholar 57.Saunders JE, Luxford WM, Devgan KK, Fetterman BL. Sudden hearing loss in acoustic neuroma patients.
Otolaryngol Head Neck Surg.1995;113:23-31.Google Scholar 58.Palomar Garcia V, Abdulghani Martinez F, Bodet Agusti E, Andreu Mencia L, Palomar Asenjo V. Drug-induced otoxicity: current status.
Acta Otolaryngol.2001;121:569-572.Google Scholar 59.Begg EJ, Barclay ML, Kirkpatrick CM. The therapeutic monitoring of antimicrobial agents.
Br J Clin Pharmacol.2001;52(suppl 1):35S-43S.Google Scholar 60.Schweitzer VG. Ototoxicity of chemotherapeutic agents.
Otolaryngol Clin North Am.1993;26:759-789.Google Scholar 61.Rybak LP. Ototoxicity of loop diuretics.
Otolaryngol Clin North Am.1993;26:829-844.Google Scholar 62.Brummett RE. Ototoxicity of vancomycin and analogues.
Otolaryngol Clin North Am.1993;26:821-828.Google Scholar 63.Brummett RE. Ototoxic liability of erythromycin and analogues.
Otolaryngol Clin North Am.1993;26:811-819.Google Scholar 64.Campbell KC, Durrant J. Audiologic monitoring for ototoxicity.
Otolaryngol Clin North Am.1993;26:903-914.Google Scholar 65.Brien JA. Ototoxicity associated with salicylates: a brief review.
Drug Saf.1993;9:143-148.Google Scholar 66.Zettner E, Folsom R, Burns E. DPOAE suppression tuning curves during salicylate ototoxicity. Paper presented at: Association for Research in Otolaryngology; February
6, 1996; St Petersburg Beach, Fla.
67.Kochkin S. MarkeTrak V. Why my hearing aids are in the drawer: the consumers'
perspective.
Hearing J.2000;53:34-42.Google Scholar 68.Ovegard A, Ramstrom AB. Individual follow-up of hearing aid fitting.
Scand Audiol.1994;23:57-63.Google Scholar 69.Popelka MM, Cruickshanks KJ, Wiley TL, Tweed TS, Klein BE, Klein R. Low prevalence of hearing aid use among older adults with hearing loss:
the epidemiology of hearing loss study.
J Am Geriatr Soc.1998;46:1075-1078.Google Scholar 70.Stephens SD, Meredith R. Physical handling of hearing aids by the elderly.
Acta Otolaryngol Suppl.1990;476:281-285.Google Scholar 71.Henrichsen J, Noring E, Christensen B.
et al. In-the-ear hearing aids: the use and benefit in the elderly hearing-impaired.
Scand Audiol.1988;17:209-212.Google Scholar 72.Yueh B. Digital hearing aids.
Arch Otolaryngol Head Neck Surg.2000;126:1394-1397.Google Scholar 73.Valente M, Sweetow R, Potts LG, Bingea B. Digital versus analog signal processing: effect of directional microphone.
J Am Acad Audiol.1999;10:133-150.Google Scholar 74.Bentler RA, Niebuhr D, Johnson T, Flamme G. The impact of digital labeling on outcome measures.
Ear Hear.In press.Google Scholar 75.Upfold L, May A, Battaglia J. Hearing aid manipulation skills in an elderly population: a comparison
of ITE, BTE, and ITC aids.
Br J Audiol.1990;24:311-318.Google Scholar 76.May A, Upfold L, Battaglia J. The advantages and disadvantages of ITC, ITE, and BTE hearing aids:
diary and interview reports from elderly users.
Br J Audiol.1990;24:301-309.Google Scholar 77.Tonning F, Warland A, Tonning K. Hearing instruments of the elderly hearing impaired.
Scand Audiol.1991;20:69-74.Google Scholar 78.Loovis CF, Schall DG, Teter DL. The role of assistive devices in the rehabilitation of hearing impairment.
Otolaryngol Clin North Am.1997;30:803-847.Google Scholar 79.Jerger J, Chmiel R, Wilson N, Luchi R. Hearing impairment in older adults: new concepts.
J Am Geriatr Soc.1995;43:928-935.Google Scholar 80.Kaplan H. Assistive devices for the elderly.
J Am Acad Audiol.1996;7:203-211.Google Scholar 82.Vartiainen E. Surgery in elderly patients with otosclerosis.
Am J Otol.1995;16:536-538.Google Scholar 83.Del Bo M, Zaghis A, Abrosetti U. Some observations concerning 200 stapedectomies: fifteen years postoperatively.
Laryngoscope.1987;97:1211-1213.Google Scholar 84.Farrario F, Spriano G, Piantanida A.
et al. Surgical treatment of otosclerosis in the elderly: a retrospective
study.
Acta Otorhinolaryngol Ital.1997;17:419-424.Google Scholar 85.Cheng AK, Rubin HR, Powe NR, Mellon NK, Francis HW, Niparko JK. Cost-utility analysis of the cochlear implant in children.
JAMA.2000;284:850-856.Google Scholar 86.Cheng AK, Niparko JK. Cost-utility of the cochlear implant in adults: a meta-analysis.
Arch Otolaryngol Head Neck Surg.1999;125:1214-1218.Google Scholar 87.Bichey BG, Hoversland JM, Wynne MK, Miyamoto RT. Changes in quality of life and the cost-utility associated with cochlear
implantation in patients with large vestibular aqueduct syndrome.
Otol Neurotol.2002;23:323-327.Google Scholar 88.Palmer CS, Niparko JK, Wyatt JR, Rothman M, de Lissovoy G. A prospective study of the cost-utility of the multichannel cochlear
implant.
Arch Otolaryngol Head Neck Surg.1999;125:1221-1228.Google Scholar